Skip to content
Wealthy Investor Report

Wealthy Investor Report

  • Home
  • Domestic
  • Business
  • Money
  • Top News
  • Newsletters
  • Home
  • 2023
  • November
  • 6
  • Bristol Myers buys Orum’s blood cancer therapy for up to $180 million
  • FILE PHOTO: A sign stands outside a Bristol Myers Squibb

FILE PHOTO: A sign stands outside a Bristol Myers Squibb

FILE PHOTO: A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo

Post navigation

Bristol Myers buys Orum’s blood cancer therapy for up to $180 million

Recent Posts

  • Airlines stick to net zero target despite green fuel doubts
  • Airlines stick to net zero target despite green fuel doubts
  • Broadcom ships latest networking chip to speed AI
  • Fed’s Bostic says current uncertainty calls for patience on rate policy
  • US job openings rebound in April; layoffs pick up

Categories

  • Business
  • Domestic
  • Economy
  • Money
  • Newsletters
  • Politics
  • Top News
  • Uncategorized
  • Privacy Policy of GBM Media Group, LLC
  • Terms of Service/Use Agreement
  • Disclaimer
  • Contact Us

Copyright © 2025 Wealthy Investor Report | Visionary News by Ascendoor | Powered by WordPress.